Unspecified complication of internal orthopedic prosthetic device, implant or graft
Conditions
Interventions
This retrospective observational study evaluated the loss of titanium implants produced by additive manufacturing placed at the Postgraduate Clinic of Univeritas University Guarulhos between 2019 and
the objective was to determine the frequency of loss of implants produced by additive manufacturing by Plenum Bioengineering, considering as loss the absence of the implant in the bone, failure of oss
Sponsors
Universidade de Guarulhos
Universidade de Guarulhos
Eligibility
Inclusion criteria
Inclusion criteria: Titanium implants manufactured by additive manufacturing (AM) by Plenum Bioengineering will be included in the study.
Exclusion criteria
Exclusion criteria: No exclusion criteria were applied for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome: It was expected that no implant losses would occur or that, if they did, the number of losses would be minimal throughout the follow-up period, considering the absence of the implant in the bone, failure of osseointegration, mobility, infection, or persistent pain as criteria for failure;Observed outcome: An initial loss of seven implants belonging to three patients was observed between 0 and 5 months after placement; these implants were subsequently rehabilitated and were not counted as failures. At 12 and 24 months, all included implants demonstrated a 100% survival rate, whereas at 36 months two implants failed in two patients without systemic conditions or smoking habits, resulting in a survival rate of 98.9%, with no further losses at the 48- and 60-month follow-ups | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactJosé Rodrigues
Universidade de Guarulhos
Outcome results
None listed